<ѻý>Meticulous Slicing No Better Than Stenting at Axing Feared TAVR Complicationѻý> Comparing leaflet splitting vs conventional stenting to avoid coronary obstruction May 16, 2023
<ѻý>EVAR vs Aneurysm Activity; Carotid Stenosis Inaccuracy; More PAP in Heart Failure?ѻý> Recent developments of interest in cardiovascular medicine May 16, 2023
<ѻý>The Worst Redo Option After TAVR?ѻý> Choose the first procedure wisely, because repeats have mortality implications, researchers say Apr 24, 2023
<ѻý>Electric Vehicle Chargers & CIEDs; Deadly Fistulas After Afib Ablation; Bony Strokesѻý> Recent developments of interest in cardiovascular medicine Apr 18, 2023
<ѻý>Transcatheter Arterialization of Deep Veins Succeeds for No-Option Limb Ischemiaѻý> Most patients avoided amputation in single-group study Mar 29, 2023
<ѻý>Pulse Oximeters Confirmed to Be Biased for Black Kidsѻý> These patients are prone to get false negatives in hypoxemia Mar 20, 2023
<ѻý>Entresto for Pre-Heart Failure; Afib and Dementia; DIY 12-Lead ECG for Patientsѻý> Recent developments of interest in cardiovascular medicine Mar 14, 2023
<ѻý>Thrombectomy Linked to Better High-Risk Pulmonary Embolism Outcomesѻý> Observational study suggests fewer deaths than with other approaches Mar 06, 2023
<ѻý>TAVR Holds Strong 3 Years Into Evolut Low Risk Trialѻý> No major widening nor narrowing of event curves yet Mar 06, 2023
<ѻý>Immediate Complete Revascularization Non-Inferior to Staged Procedureѻý> Patients with ACS and multivessel disease saw multiple outcome benefits in BIOVASC trial Mar 05, 2023
<ѻý>Hunt for Hibernating Myocardium Doesn't Help PCI for Ischemic Cardiomyopathyѻý> REVIVED-BCIS2 challenges long-held beliefs about myocardial viability Mar 05, 2023
<ѻý>Interventional Cardiology Gets Codified Rules for Trainingѻý> Multi-society recommendations cover minimum procedural volumes, competencies Feb 16, 2023
<ѻý>Weight Loss Pill Warning; Very Low LDL-C Stays Course; Fungal Growth on TAVR Valveѻý> Recent developments of interest in cardiovascular medicine Feb 14, 2023
<ѻý>Stroke Neuroprotection Drug Passes Early-Phase Hurdleѻý> Infusion before mechanical thrombectomy reduced important outcomes in small phase I/II trial Feb 08, 2023
<ѻý>Arrival of TEER Has Helped Surgeons' Track Recordsѻý> Nationwide analysis of technology's effect since FDA approval 10 years ago Feb 06, 2023
<ѻý>Yelp Reviews in Cardiology; Viagra's Unfulfilled Promise; Catheter RDN at 10 Yearsѻý> Recent developments of interest in cardiovascular medicine Jan 31, 2023
<ѻý>Bypass Surgery for Multivessel CAD Reaffirmed in Newer Dataѻý> Surgeons fire back at downgrading of CABG in recent guidelines Jan 23, 2023
<ѻý>Involve Anesthesiologists in Procedural Suite Design?ѻý> Accommodating anesthesiologists' needs could make an impact on patient safety, experts say Jan 13, 2023
<ѻý>Anesthesia Outside of the OR: Cause for Patient Safety Concerns?ѻý> Studies have shown harms for non-OR anesthesia (NORA); experts say changes are needed Jan 13, 2023
<ѻý>Cardiologists' Mental Disorders; NFL Player's Cardiac Arrest; Red Flag for Turmericѻý> Recent developments of interest in cardiovascular medicine Jan 03, 2023
<ѻý>Stroke Thrombectomy Beyond the 24-Hour Window: Study Keeps the Door Openѻý> Researchers push the boundaries of how late is too late for intervention Dec 27, 2022
<ѻý>Cath Labs Vary Widely in Cardiac Arrest Survivalѻý> "Call to action" sounded on study findings Dec 19, 2022
<ѻý>Cape Cod Cardiologist Sues Hospital, Alleging Retaliation for Whistleblowingѻý> Richard Zelman, MD, also alleges that Cape Cod Hospital breached his contract Dec 09, 2022
<ѻý>Aortic Aneurysm Score Paves the Way for More Targeted Screeningѻý> Could EHR data help narrow down candidates for imaging? Nov 15, 2022
<ѻý>Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMIѻý> BRIGHT-4 trial hands the drug a "clear, unambiguous win" against heparin Nov 07, 2022
<ѻý>Early Invasive Strategy for Stable CAD Holds No Long-Term Survival Advantageѻý> Extended follow-up of ISCHEMIA trial weighs in on mortality Nov 07, 2022
<ѻý>Catheter-Directed Thrombolysis Promising for Intermediate-Risk Pulmonary Embolismѻý> Strategy may mitigate the drawback of major bleeding Oct 19, 2022
<ѻý>SCAD Heart Attacks: Outcomes Not as Bad as Previously Fearedѻý> Low 3-year MACE rates seen in a more representative spontaneous coronary artery dissection cohort Oct 17, 2022
<ѻý>Clopidogrel Recall; COAPT Score; Pediatric Cardiologist's Child Pornѻý> Recent developments of interest in cardiovascular medicine Oct 04, 2022
<ѻý>Keeping Plavix After Short DAPT: Bleeding Benefit Emerges a Few Years After PCIѻý> Antiplatelet strategy has good results in longer follow-up of SMART-CHOICE trial Sep 29, 2022
<ѻý>Brief Anticoagulation Preserves Radial Artery After Catheter Accessѻý> Trial shows promise of a short course of direct-acting oral anticoagulant Sep 20, 2022
<ѻý>PCI vs CABG: Does Age Inform Choice for Left Main Coronary Artery Disease?ѻý> Swedish registry study contributes to ongoing controversy Sep 19, 2022
<ѻý>Pulmonary Artery Denervation Improves PAH Symptomsѻý> Trial promising for novel technique Sep 19, 2022
<ѻý>RDN Powers Through Another Off-Med Trial, Clinical Benefits Still Untestedѻý> Plus, an apparent magnification of effect in SYMPLICITY HTN-3 Sep 19, 2022
<ѻý>PCI Not (Much) Worse Than CABG for Multivessel Disease Long Termѻý> Extended follow-up of BEST trial appeared unlikely to change minds, though Sep 19, 2022
<ѻý>Ultrasound Guidance No Advantage for PCI Accessѻý> But randomized trial still suggests some reasons to consider this readily available intervention Sep 18, 2022
<ѻý>MitraClip G4 Sets the Bar Higher for Transcatheter Edge-to-Edge Repairѻý> Post-approval study suggests growing pool of TEER-suitable patients Sep 18, 2022
<ѻý>Clot Grabber Safe, Promising in Intermediate-Risk PEѻý> Registry supports expanding use of interventional treatment Sep 18, 2022
<ѻý>Is TAVR in Small Aortic Annuli Better With Self-Expanding Valves?ѻý> Registry supports mortality impact of patient-prosthesis mismatch Sep 17, 2022
<ѻý>Mitral Valve Repair Devices Go Head-to-Head, and the Top Spot Belongs to...ѻý> CLASP IID trial crowns no winner but champions expanding choices Sep 17, 2022